Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Virchows Archiv : an International Journal of Pathology|November 8, 2022
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)Alberto Pisacane, Eliano Cascardi, Enrico Berrino, et al.Cancer Research|January 23, 2014
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitorsPaolo Luraghi, Gigliola Reato, Elia Cipriano, et al.Nature Communications|June 1, 2017
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancerClaudio Isella, Francesco Brundu, Sara E Bellomo, et al.EMBO Molecular Medicine|February 1, 2023
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primarySerena Brundu, Virginia Napolitano, Giulia Franzolin, et al.Cancer Research|June 29, 2012
The MET oncogene is a functional marker of a glioblastoma stem cell subtypeFrancesca De Bacco, Elena Casanova, Enzo Medico, et al.Nature Communications|May 4, 2021
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibitionFederica Verginelli, Alberto Pisacane, Gennaro Gambardella, et al.International Journal of Molecular Sciences|October 27, 2022
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor PrecursorDogus Murat Altintas, Simona Gallo, Cristina Basilico, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|May 15, 2020
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypesFrancesca Orzan, Francesca Pagani, Manuela Cominelli, et al.Cell Reports|July 28, 2021
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastomaFrancesca De Bacco, Francesca Orzan, Jessica Erriquez, et al.EMBO Molecular Medicine|May 4, 2016
MET inhibition overcomes radiation resistance of glioblastoma stem-like cellsFrancesca De Bacco, Antonio D'Ambrosio, Elena Casanova, et al.Pageof 5